Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients [Phase 2]

View source ↗

Summary

A multicenter Phase II randomized, double-blind, placebo-controlled dose-exploration trial evaluates the efficacy, safety, and pharmacokinetics of STC314 given …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• STC314

Snippet

Sponsor: Grand Medical Pty Ltd. | Conditions: Sepsis | Phase 2 | Status: ACTIVE_NOT_RECRUITING